Table 2 The association between the median of hospitalization cost and the potential risk factors using quantile regression in patients with ≤ 9 and > 9 hospitalization days
Covariate | ≤ 9 Days | > 9 Days | ||
|---|---|---|---|---|
Estimate (95% CI) | P-value | Estimate (95% CI) | P-value | |
Gender (male) | ||||
Female | 0.10 (0.0,0.20) | 0.058 | 0.09 (− 0.13,0.31) | 0.431 |
Age (< 60 year) | ||||
≥ 60 year | − 0.08 (− 0.19,0.03) | 0.172 | − 0.27 (− 0.51,− 0.02) | 0.031 |
Comorbidity disease (no) | ||||
Diabetes | − 0.01 (− 0.22,0.20) | 0.924 | − 0.28 (− 0.66,0.10) | 0.147 |
Cardiovascular | 0.28 (0.10,0.46) | 0.003 | 0.43 (0.0,0.86) | 0.048 |
Hypertension | 0.09 (− 0.06,0.23) | 0.241 | − 0.01 (− 0.32,0.3) | 0.969 |
Multiple | − 0.04 (− 0.21,0.12) | 0.619 | − 0.11 (− 0.41,0.19) | 0.473 |
Pulmonary lung (normal) | ||||
Crackling (rales) | − 0.03 (− 0.16,0.10) | 0.644 | − 0.04 (− 0.3,0.22) | 0.780 |
Wheezing | 0.4 (0.02,0.78) | 0.042 | 0.36 (− 0.47,1.20) | 0.392 |
SPO2 (> 90) | ||||
≤ 90 | 0.2 (0.09,0.31) | < 0.001 | 0.04 (− 0.32,0.39) | 0.844 |
CRP (negative) | ||||
Positive | 0.2 (0.08,0.32) | 0.002 | 0.08 (− 0.20,0.35) | 0.586 |
PT (11–13 Sec) | ||||
> 13 | − 0.07 (− 0.17,0.04) | 0.216 | − 0.19 (− 0.42,0.05) | 0.125 |
LDH (≤ 942 U/L) | ||||
> 942 | 0.46 (0.25,0.67) | < 0.001 | 0.04 (− 0.24,0.32) | 0.788 |
NA (136–145 mEq/L) | ||||
< 136 | 0.15 (0.03,0.27) | 0.012 | 0.09 (− 0.12,0.30) | 0.391 |
> 145 | 0.37 (− 0.13,0.86) | 0.144 | 0.52 (− 0.90,1.94) | 0.469 |
K (3.5–5.1 mEq/L) | ||||
< 3.5 | − 0.17 (− 0.37,0.04) | 0.117 | − 0.16 (− 0.57,0.25) | 0.434 |
> 5.1 | 0.21 (− 0.17,0.59) | 0.282 | − 0.07 (− 0.64,0.51) | 0.821 |
Lymphocytes (20–40%) | ||||
< 20 | 0.13 (0.01,0.24) | 0.039 | 0.05 (− 0.18,0.28) | 0.667 |
> 40 | 0.41 (− 0.12,0.94) | 0.131 | 0.12 (− 1.38,1.61) | 0.879 |
WBC (4.5–11 mg/dL) | ||||
< 4.5 | 0.03 (− 0.09,0.15) | 0.634 | − 0.31 (− 0.56,− 0.05) | 0.018 |
> 11 | 0.08 (− 0.12,0.28) | 0.417 | 0.15 (− 0.27,0.57) | 0.474 |
ICU (no) | ||||
Yes | 0.69 (0.54,0.84) | < 0.001 | 1.01 (0.79,1.22) | < 0.001 |